Cargando…

Targeting autophagy in cancer management – strategies and developments

Autophagy is a highly regulated catabolic process involving lysosomal degradation of intracellular components, damaged organelles, misfolded proteins, and toxic aggregates, reducing oxidative stress and protecting cells from damage. The process is also induced in response to various conditions, incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozpolat, Bulent, Benbrook, Doris M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573074/ https://www.ncbi.nlm.nih.gov/pubmed/26392787 http://dx.doi.org/10.2147/CMAR.S34859

Ejemplares similares

Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer
por: Hasima, N, et al.
Publicado: (2014)

Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies
por: Ozyurt, Rumeysa, et al.
Publicado: (2022)

Mechanisms of PARP-Inhibitor-Resistance in BRCA-Mutated Breast Cancer and New Therapeutic Approaches
por: Dilmac, Sayra, et al.
Publicado: (2023)

The Dual Role of Autophagy in Cancer Development and a Therapeutic Strategy for Cancer by Targeting Autophagy
por: Yun, Chul Won, et al.
Publicado: (2020)

Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy
por: Shin, Dong Ho, et al.
Publicado: (2021)

The Role of LncRNAs in Translation
por: Karakas, Didem, et al.
Publicado: (2021)

The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells
por: Arun, Banu, et al.
Publicado: (2015)

Similarities and Differences of Hsp70, hsc70, Grp78 and Mortalin as Cancer Biomarkers and Drug Targets
por: Rai, Rajani, et al.
Publicado: (2021)

Non-coding RNAs regulation of macrophage polarization in cancer
por: Mohapatra, Swati, et al.
Publicado: (2021)

miRacle of microRNA-Driven Cancer Nanotherapeutics
por: Kara, Goknur, et al.
Publicado: (2022)

Therapeutic options for management of endometrial hyperplasia
por: Chandra, Vishal, et al.
Publicado: (2016)

SHetA2 Attack on Mortalin and Colleagues in Cancer Therapy and Prevention
por: Benbrook, Doris Mangiaracina
Publicado: (2022)

Histopathologic, Genetic and Molecular Characterization of Endometrial Cancer Racial Disparity
por: Javadian, Pouya, et al.
Publicado: (2021)

Targeting Autophagy for Developing New Therapeutic Strategy in Intervertebral Disc Degeneration
por: Bahar, Md Entaz, et al.
Publicado: (2022)

Targeting autophagy as a therapeutic strategy against pancreatic cancer
por: Yamamoto, Keisuke, et al.
Publicado: (2022)

Mullerian Inhibiting Substance Suppresses Proliferation and Induces Apoptosis and Autophagy in Endometriosis Cells In Vitro
por: Borahay, Mostafa A., et al.
Publicado: (2013)

Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy
por: Griffith, James, et al.
Publicado: (2017)

The apoptotic effect of 1’S-1’-Acetoxychavicol Acetate (ACA) enhanced by inhibition of non-canonical autophagy in human non-small cell lung cancer cells
por: Sok, Sophia P. M., et al.
Publicado: (2017)

Targeting autophagy in disease: established and new strategies
por: Kocak, Muhammed, et al.
Publicado: (2021)

Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment
por: Cordani, Marco, et al.
Publicado: (2018)

Identification of Candidate Biomarker and Drug Targets for Improving Endometrial Cancer Racial Disparities
por: Javadian, Pouya, et al.
Publicado: (2022)

Dataset on mucin 1 and 4 proteins and SialyT and T antigens staining patterns in cervical cancer primary tumors and metastatic lymph nodes
por: Rai, Rajani, et al.
Publicado: (2023)

Utility and Mechanism of SHetA2 and Paclitaxel for Treatment of Endometrial Cancer
por: Chandra, Vishal, et al.
Publicado: (2021)

Therapeutic Aspects and Molecular Targets of Autophagy to Control Pancreatic Cancer Management
por: Rahman, Md. Ataur, et al.
Publicado: (2022)

Modeling effects of diabetes and obesity co-morbidities in endometrial cancer development and progression
por: Benbrook, Doris, et al.
Publicado: (2012)

Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2
por: Sharma, Ankur, et al.
Publicado: (2018)

FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells
por: Hamurcu, Zuhal, et al.
Publicado: (2016)

Targeting Autophagy in Breast Cancer
por: Cocco, Stefania, et al.
Publicado: (2020)

Bioanalytical method development and validation of HPLCUV assay for the quantification of SHetA2 in mouse and human plasma: Application to pharmacokinetics study
por: Sharma, Ankur, et al.
Publicado: (2017)

Modulating autophagy: a strategy for cancer therapy
por: Li, Jun-Lin, et al.
Publicado: (2011)

Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth
por: Olmez, Inan, et al.
Publicado: (2015)

Making the Case for Autophagy Inhibition as a Therapeutic Strategy in Combination with Androgen-Targeted Therapies in Prostate Cancer
por: Elshazly, Ahmed M., et al.
Publicado: (2023)

Down-Regulation of 5-HT(1B) and 5-HT(1D) Receptors Inhibits Proliferation, Clonogenicity and Invasion of Human Pancreatic Cancer Cells
por: Gurbuz, Nilgun, et al.
Publicado: (2014)

Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy
por: Koustas, Evangelos, et al.
Publicado: (2021)

Targeting Autophagy in ALK-Associated Cancers
por: Frentzel, Julie, et al.
Publicado: (2017)

Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment
por: Yoshida, Go J.
Publicado: (2017)

Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer
por: Tekedereli, Ibrahim, et al.
Publicado: (2013)

Targeting autophagy to overcome drug resistance: further developments
por: Chang, Haocai, et al.
Publicado: (2020)

Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance
por: Carew, Jennifer S, et al.
Publicado: (2008)

Control of the Autophagy Pathway in Osteoarthritis: Key Regulators, Therapeutic Targets and Therapeutic Strategies
por: Valenti, Maria Teresa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_13a63mv75eulksk1pnmgqv3n5u